Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 197Gastrointestinal 84Thoracic 7Breast 7Genitourinary 4Other solid neoplasm 3Endocrine 3Sarcoma 2Head & Neck 1CNS 1

Conditions

Head and Neck Neoplasms 2095Squamous Cell Carcinoma of Head and Neck 1649Nasopharyngeal Carcinoma 517Thyroid Neoplasms 477Carcinoma, Non-Small-Cell Lung 435Breast Neoplasms 314Mouth Neoplasms 312Neoplasms 309Melanoma 299Oropharyngeal Neoplasms 285Colorectal Neoplasms 272Lung Neoplasms 246Carcinoma, Squamous Cell 239Neoplasm Metastasis 235Ovarian Neoplasms 226Uterine Cervical Neoplasms 202Stomach Neoplasms 195Salivary Gland Neoplasms 192Laryngeal Neoplasms 192Nasopharyngeal Neoplasms 188Carcinoma, Renal Cell 182Esophageal Neoplasms 179Pancreatic Neoplasms 176Prostatic Neoplasms 157Sarcoma 142Urinary Bladder Neoplasms 135Triple Negative Breast Neoplasms 134Recurrence 127Endometrial Neoplasms 123Hypopharyngeal Neoplasms 121

Interventions

tremelimumab 1durvalumab 1Oxaliplatin 1Leucovorin 1Gemcitabine 1Fluorouracil 1EC regimen 1Cisplatin 1Carboplatin 1CP protocol 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Peritoneal Neoplasms × Head & Neck × Clear all
NCT02658214 2020-08-20

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

AstraZeneca

Phase 1 Completed
32 enrolled
BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡